Effects of Glucagon-like Peptide-1 on the Reproductive Axis in Healthy Men.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 06 12 2019
accepted: 10 02 2020
pubmed: 14 2 2020
medline: 5 1 2021
entrez: 14 2 2020
Statut: ppublish

Résumé

Glucagon-like peptide-1 (GLP-1) potently reduces food intake and augments glucose-stimulated insulin secretion. Recent animal data suggest that GLP-1 may also influence reproduction. As GLP-1 receptor agonists are currently widely used in clinical practice to treat obesity/type 2 diabetes, it is necessary to determine the effects of GLP-1 on the reproductive system in humans. To investigate the effects of GLP-1 administration on the reproductive axis in humans. Single-blind, randomized, placebo-controlled crossover study. Clinical Research Facility, Imperial College Healthcare NHS Trust. Eighteen healthy men (mean age 24.7 ± 0.1years, mean BMI 22.1 ± 0.4kg/m2). Eight-hour intravenous infusion of 0.8 pmol/kg/min GLP-1 or rate-matched vehicle infusion. Number of luteinizing hormone (LH) pulses, LH, follicle-stimulating hormone (FSH), and testosterone levels. The number of LH pulses (number of LH pulses/500 min: vehicle 4.2 ± 0.4, GLP-1 4.5 ± 0.3, P = 0.46), LH area under the curve (AUC) (vehicle 1518 ± 88min.IU/L, GLP-1 1524 ± 101min.IU/L, P = 0.95), follicle-stimulating hormone AUC (vehicle 1210 ± 112 min IU/L, GLP-1 1216 ± 112 min IU/L, P = 0.86), and testosterone AUC (vehicle 10893 ± 615 min nmol/L, GLP-1 11088 ± 792 min nmol/L, P = 0.77) did not significantly differ during vehicle and GLP-1 administration. Glucagon-like peptide-1 significantly reduced food intake (vehicle 15.7 ± 1.3 kcal/kg, GLP-1 13.4 ± 1.3 kcal/kg, P = 0.01). In contrast to the animal literature, our data demonstrate that acute GLP-1 administration does not affect reproductive hormone secretion in healthy men.

Identifiants

pubmed: 32052032
pii: 5735220
doi: 10.1210/clinem/dgaa072
pmc: PMC7082082
pii:
doi:

Substances chimiques

Biomarkers 0
Incretins 0
Glucagon-Like Peptide 1 89750-14-1
Glucagon 9007-92-5

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/N020472/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R000484/1
Pays : United Kingdom
Organisme : Department of Health
ID : CS-2018-18-ST2-002
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T006242/1
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2014-05-001
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004171/1
Pays : United Kingdom

Informations de copyright

© Endocrine Society 2020.

Références

BMJ. 1990 Jan 27;300(6719):230-5
pubmed: 2106931
J Clin Endocrinol Metab. 2001 Oct;86(10):4913-9
pubmed: 11600562
Endocr Connect. 2019 Mar 1;8(3):195-202
pubmed: 30707677
J Clin Endocrinol Metab. 2014 Jun;99(6):E953-61
pubmed: 24517142
Am J Physiol Endocrinol Metab. 2001 Jul;281(1):E155-61
pubmed: 11404233
Eur J Clin Invest. 2005 Sep;35(9):565-72
pubmed: 16128863
Gut. 1999 Jan;44(1):81-6
pubmed: 9862830
Diabetes Care. 2018 Jul;41(7):1516-1525
pubmed: 29934480
J Clin Endocrinol Metab. 1998 Jun;83(6):1967-75
pubmed: 9626127
Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E724-30
pubmed: 22252939
J Clin Invest. 2002 Jul;110(1):43-52
pubmed: 12093887
Diabetes. 2014 Nov;63(11):3711-20
pubmed: 24939425
eNeuro. 2017 Jan 20;4(1):
pubmed: 28144621
Lancet. 1987 Dec 5;2(8571):1300-4
pubmed: 2890903
Endocrinology. 2015 Nov;156(11):4226-37
pubmed: 26252058
N Engl J Med. 2010 Jul 8;363(2):109-22
pubmed: 20592293
Andrology. 2015 Nov;3(6):1094-103
pubmed: 26447645
Science. 1980 Mar 21;207(4437):1371-3
pubmed: 6766566
J Clin Invest. 1998 Mar 15;101(6):1334-41
pubmed: 9502775
Biol Reprod. 2017 Aug 1;97(2):240-248
pubmed: 29044434
Sci Rep. 2019 Sep 19;9(1):12986
pubmed: 31537818
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
Science. 1986 Feb 7;231(4738):607-9
pubmed: 3003907
Endocrinology. 1998 Jul;139(7):3088-95
pubmed: 9645680

Auteurs

Chioma Izzi-Engbeaya (C)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Sophie Jones (S)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Yoshibye Crustna (Y)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Pratibha C Machenahalli (PC)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Deborah Papadopoulou (D)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Manish Modi (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Christos Panayi (C)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Jessica Starikova (J)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Pei Chia Eng (PC)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Maria Phylactou (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Edouard Mills (E)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Lisa Yang (L)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Risheka Ratnasabapathy (R)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Mark Sykes (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Isabella Plumptre (I)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Ben Coumbe (B)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Victoria C Wing (VC)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Ewa Pacuszka (E)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Paul Bech (P)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

James Minnion (J)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

George Tharakan (G)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Acute Medicine, Imperial College Healthcare NHS Trust, London, UK.

Tricia Tan (T)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Johannes Veldhuis (J)

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Ali Abbara (A)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Alexander N Comninos (AN)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Waljit S Dhillo (WS)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH